Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
20.23
+0.26 (1.30%)
At close: Dec 20, 2024, 4:00 PM
19.31
-0.92 (-4.55%)
After-hours: Dec 20, 2024, 4:03 PM EST
Company Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally.
The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes.
It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Embecta Corp.
| Country | United States |
| Founded | 1924 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 2,200 |
| CEO | Devdatt Kurdikar |
Contact Details
Address: 300 Kimball Drive, Suite 300 Parsippany, New Jersey 07054 United States | |
| Phone | 862 401 0000 |
| Website | embecta.com |
Stock Details
| Ticker Symbol | EMBC |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001872789 |
| CUSIP Number | 29082K105 |
| ISIN Number | US29082K1051 |
| Employer ID | 87-1583942 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Devdatt Kurdikar | President, Chief Executive Officer and Director |
| Jacob P. Elguicze | Senior Vice President and Chief Financial Officer |
| Jeffrey Z. Mann | Senior Vice President, General Counsel, Head of Business Development and Corporate Secretary |
| Shaun Curtis | Senior Vice President of Global Manufacturing and Supply Chain |
| Colleen Riley | Senior Vice President and Chief Technology Officer |
| Pravesh Khandelwal | Vice President and Head of Investor Relations |
| Ginny Blocki | Senior Vice President of Global Marketing and Product Management |
| Jean M. Casner | Senior Vice President and Chief Human Resources Officer |
| Tom Blount | Senior Vice President and President of North America |
| Slobodan Radumilo | Senior Vice President and President of International |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 19, 2024 | ARS | Filing |
| Dec 19, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Dec 19, 2024 | DEF 14A | Other definitive proxy statements |
| Dec 11, 2024 | 10-K | Annual Report |
| Dec 2, 2024 | 8-K | Current Report |
| Nov 29, 2024 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
| Nov 26, 2024 | 8-K | Current Report |
| Nov 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 7, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Oct 25, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |